<DOC>
	<DOCNO>NCT00065286</DOCNO>
	<brief_summary>Akathisia movement disorder often side effect certain psychiatric drug . People akathisia unable sit keep still , complain restlessness , fidget , rock foot foot , pace . Akathisia sometimes call “ restless leg syndrome. ” The drug cause akathisia often use treat patient schizophrenia mental retardation ( MR ) . This study evaluate akathisia schizophrenic MR patient either long-term akathisia start treatment psychiatric drug .</brief_summary>
	<brief_title>Akathisia ( Restless Legs Syndrome ) People With Schizophrenia Mental Retardation</brief_title>
	<detailed_description>Akathisia relatively common side effect neuroleptic medication occur within 1 week 6 month initiation medication . Akathisia characterize variety movement manifestation , fidget , irritability , inability sit stand still , march place , continuous trunk motion , sleeplessness , subjective sense restlessness . Akathisia study primarily schizophrenic patient , although report individual mental retardation suggest akathisia also occur population . This study characterize movement dynamic akathisia schizophrenic mentally retarded adult use two experimental series . The first experimental series compare chronic akathisia schizophrenic MR patient . Four group MR patient four group schizophrenic patient study : young ( age 18 38 ) chronic akathisia , old ( age 40 60 ) chronic akathisia , young neuroleptic without akathisia , old neuroleptic without akathisia . Two control group include healthy individual normal intelligence neuroleptic medication . Assessments include videotaped recording kinematic analysis naturally occur akathisia restlessness movement well cognitive psychiatric test . Demographic factor ( age sex ) medication factor ( type duration ) also assess determine relation possible impact chronic akathisia . The second experimental series compare schizophrenic MR patient initiate neuroleptic therapy . Institutionalized MR patient age match schizophrenic patient . Tests occur baseline ( prior drug initiation ) Weeks 1 , 2 , 4 , 8 , 16 , 24 , 52 . Those enroll protocol early test 12 month possible useful . The analysis first experimental series use allow comparison acute chronic akathisia .</detailed_description>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Intellectual Disability</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<criteria>Inclusion Criteria Experimental Series I Chronic akathisia least 3 month prior study entry Neuroleptic medication least 6 month prior study entry ( anticonvulsant medication accept carbamazepine ethosuximide monitor development akathisia ) Mental retardation/developmental delay diagnosis base American Association Mental Deficiency definition diagnosis schizophrenia base DSMIV criterion Inclusion Criteria Control Group Control group match akathisia group base age level disability ( IQ mental retardation population , BPRS positive symptom schizophrenia schizophrenic group ) . Exclusion Criteria Psychotropic drug serotonin reuptake inhibiting antidepressant Nonambulatory Uncontrolled seizure disorder Fragile X syndrome Down Syndrome Neurological disease know definitive symptom choreoathetosis , dystonia , Syndenham 's chorea , etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2003</verification_date>
	<keyword>Akathisia</keyword>
	<keyword>Mental retardation</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Neuroleptic medication</keyword>
	<keyword>Tardive dyskinesia</keyword>
	<keyword>Brief Psychiatric Rating Scale</keyword>
	<keyword>Barnes test</keyword>
	<keyword>Stereotypy Checklist Test</keyword>
	<keyword>DISCUS Tardive Dyskinesia test</keyword>
</DOC>